Search for Chlamydia pneumoniae genes and their expression in atherosclerotic plaques of carotid arteries

Journal of Medical Microbiology

Volumn 50, Issue 3, 2001, Pages 228-232

  Valassina, M ^a   Migliorini, L ^a   Sansoni, A ^a   Sani, G ^a   Corsaro, D ^a   Cusi, M G ^a   Valensin, P E ^a   Cellesi, C ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HEAT SHOCK PROTEIN 70; PROTEIN OMP1; RNA 16S; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BACTERIAL GENE; BACTERIAL OUTER MEMBRANE; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CAROTID ARTERY; CAROTID ARTERY SURGERY; CHLAMYDOPHILA PNEUMONIAE; CHRONICITY; FEMALE; GENOME; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENICITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE CULTURE;

CHLAMYDIA PNEUMONIAE;

EID: 0035113292     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-50-3-228     Document Type: Article

References (48)

1. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections
2. The relation between Chlamydia pneumoniae and atherosclerosis
3. Chlamydia pneumoniae and atherosclerosis
4. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old)
5. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical strain
6. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease
7. Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis
8. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azytromycin in male survivors of myocardial infarction
9. Treatment with the antibiotic roixithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS study
10. Antibiotic treatment trials for secondary prevention of coronary artery disease events
11. Lack of association between first myocardial infarction and part use of erythromycin, tetracycline, or doxycycline
12. Historical review of research on atherosclerosis
13. Does atherosclerosis have an infectious etiology?
14. Infection and atherosclerosis: Emerging mechanistic paradigms
15. Chronic infections and coronary heart disease: Is there a link?
16. Infections: A cause of artery-clogging plaques?
17. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy
18. Lack of evidence for a pathogenic role of Chlamydia pneumoniae and cytomegalovirus infection in coronary atheroma formation
19. Chlamydia pneumoniae infection is frequent but not associated with coronary arteriosclerosis in cardiac transplant recipients
20. Lack of assocation between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis
21. Failure to demonstrate Chlamydia pneumoniae in symptomatic abdominal aortic aneurysms by a nested polymerase chain reaction (PCR)
22. Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients
23. Failure to detect Chlamydia pneumoniae in calcific and degenerative arteriosclerotic aortic valves excised during open heart surgery
24. Detection of mRNA by reverse transcription-PCR as an indicator of viability in Escherichia coli cells
25. A reverse transcriptase-PCR based assay for in-vitro antibiotic susceptibility testing of Chlamydia pneumoniae
26. Monitoring of Chlamydia trachomatis infections after antibiotic treatment using RNA detection by nucleic acid sequence based amplification
27. Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease
28. Persistent chlamydiae: From cell culture to a paradigm for chlamydial pathogenesis
29. RNA synthesis in cells infected with the meningopneumonitis agent
30. Preparation and chemical composition of the cell membranes of developmental reticulate forms of meningopneumonitis organisms
31. Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae
32. Detection by multiplex polymerase chain reaction and typing of Chlamydia trachomatis isolates
33. Multiplex PCR for rapid and differential diagnosis of Mycoplasma pneumoniae and Chlamydia pneumoniae in respiratory infections
34. Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene
35. Simple and rapid preparation of samples for PCR
36. Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction
37. Isolation and complete sequence of a functional human glyceraldeyde-3-phosphate-dehydrogenase gene
38. Rapid detection of different RNA respiratory virus species by multiplex RT-PCR: Application to clinical specimens
39. Virus-induced atherosclerosis
40. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis
41. Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease
42. Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon-gamma: Role of tryptophan catabolism
43. The pathogenesis of atherosclerosis: A perspective for the 1990s
44. Molecular biology of Chlamydia pneumoniae surface proteins and their role in immunopathogenicity
45. Chlamydia infections and heart disease linked through antigenic mimicry
46. Chlamydial heat shock proteins and disease pathology: New paradigms for old problems?
47. Chlamydia pneumoniae in abdominal aortic aneurysms: Abundance of membrane components in the absence of heat shock protein 60 and DNA